Search hospitals > Michigan > Pontiac
Saint Joseph Mercy Oakland
Claim this profilePontiac, Michigan 48341
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Ovarian Cancer
Conducts research for Cancer
477 reported clinical trials
10 medical researchers
Summary
Saint Joseph Mercy Oakland is a medical facility located in Pontiac, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Ovarian Cancer, Cancer and other specialties. Saint Joseph Mercy Oakland is involved with conducting 477 clinical trials across 522 conditions. There are 10 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Tareq Al BaghdadiGenesys Hurley Cancer Institute8 years of reported clinical research
Expert in Cancer
Expert in Pancreatic Cancer
73 reported clinical trials
130 drugs studied
Christopher M. Reynolds, MDSaint Joseph Mercy Hospital2 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
51 reported clinical trials
104 drugs studied
Philip J. StellaSaint Joseph Mercy Hospital5 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
38 reported clinical trials
89 drugs studied
Elie G. DibGenesys Hurley Cancer Institute6 years of reported clinical research
Studies Multiple Myeloma
Studies Breast Cancer
38 reported clinical trials
105 drugs studied
Clinical Trials running at Saint Joseph Mercy Oakland
Lung Cancer
Breast Cancer
Bladder Cancer
Prostate Cancer
Breast cancer
Ovarian Cancer
Esophageal cancer
Multiple Myeloma
Cancer
Bladder Carcinoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Joseph Mercy Oakland?
Saint Joseph Mercy Oakland is a medical facility located in Pontiac, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Ovarian Cancer, Cancer and other specialties. Saint Joseph Mercy Oakland is involved with conducting 477 clinical trials across 522 conditions. There are 10 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Where is Saint Joseph Mercy Oakland located?
Saint Joseph Mercy Oakland Hospital is located at 44405 Woodward Ave, Pontiac, MI. It is approximately a 2-minute walk from the bus stop at Woodward + South Blvd.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Saint Joseph Mercy Oakland, contact a Saint Joseph's Financial Counselor at (914) 751-0372 or a St. Vincent's Financial Counselor at (914) 925-5492. For insurance inquiries, contact the billing department at 800-494-5797.
What insurance does Saint Joseph Mercy Oakland accept?
Saint Joseph Mercy Oakland Hospital accepts a variety of insurance plans, such as Aetna, BCBS/Federal/PPO/Preferred, BCN Advantage MyBlue, and BCN HMO, among others. Accepted insurances may differ by practice or office location within the Trinity Health IHA Medical Group. It's advised to confirm insurance acceptance with your specific office or practice, and verify coverage with your employer or insurance company before seeking non-emergency treatment.
What awards or recognition has Saint Joseph Mercy Oakland received?
Saint Joseph Mercy Oakland, located in Pontiac, Michigan, is a distinguished national teaching hospital, consistently ranking in the top 10 percent for patient safety, quality, and performance. It is part of St. Joseph's Health System, which received $499,999 in NIH funding in 2010.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.